Results 111 to 120 of about 16,595,815 (334)
News From the Field; A Nation-wide Study of Junior College Terminal Education
openalex +2 more sources
An outline for institutional education and treatment of young offenders. [PDF]
William Healy, Augusta F. Bronner
openalex +1 more source
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh+5 more
wiley +1 more source
Speech education in secondary schools— a bibliography [PDF]
Elmer Harrison Wilds
openalex +1 more source
RKIP, a metastasis suppressor protein, modulates key oncogenic pathways in lung adenocarcinoma. In silico analyses linked low RKIP expression to poor survival. Functional studies revealed RKIP overexpression reduces tumor aggressiveness and enhances sensitivity to EGFR‐targeted therapies, while its loss promotes resistance.
Ana Raquel‐Cunha+10 more
wiley +1 more source
Spring 2008, Four UNH students named recipients of national awards for academic work abroad in 2008-2009 [PDF]
The Fulbright U.S. Student Program has awarded UNH seniors Erin Kiley and Lisa Mulvey prestigious national scholarships for post-baccalaureate work abroad in the coming academic year. Sophomore Jordan Caley and junior Holly Eaton will study abroad during
Center for International Education
core +1 more source
A History of Secondary Education in Pennsylvania
C. B. Allen, James Mulhern
openalex +2 more sources
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou+5 more
wiley +1 more source
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham+21 more
wiley +1 more source